Citation Tools

Extended report
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme

Download to a citation manager

Cite this article as:
Curtis JR, Lee EB, Kaplan IV, et al
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme